These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7485082)

  • 21. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
    Griesser DH
    Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autocrine IL-2-dependent growth of a newly established CD3+, CD16-, CD56+, CD57+, J(H)-, TCRbeta-, TCRgamma- leukemia cell line (NOI-90).
    Sahraoui Y; Perraki M; Theodoropoulou M; Allouche M; Tsapis A; Ammar A; Clemenceau C; Bokogiorgou S; Yacci T; Katrinakis G; Jasmin C; Georgoulias V
    Leukemia; 1997 Feb; 11(2):245-52. PubMed ID: 9009088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in T-cell-receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: implications on cellular origin.
    Chiang AK; Srivastava G; Lau PW; Ho FC
    Hum Pathol; 1996 Jul; 27(7):701-7. PubMed ID: 8698315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High grade malignant lymphoma with clinical characteristics and immunophenotype of natural killer cells.
    Schleiffenbaum B; Rüegg R; Zimmermann D; Fehr J
    Am J Hematol; 1995 Jul; 49(3):221-31. PubMed ID: 7541603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clarification of CD3 immunoreactivity in nasal T/natural killer cell lymphomas: the neoplastic cells are often CD3 epsilon+.
    Chan JK; Tsang WY; Ng CS
    Blood; 1996 Jan; 87(2):839-41. PubMed ID: 8555511
    [No Abstract]   [Full Text] [Related]  

  • 26. Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications.
    García-Sanz R; González M; Orfão A; Moro MJ; Hernández JM; Borrego D; Carnero M; Casanova F; Bárez A; Jiménez R; Portero JA; San Miguel JF
    Br J Haematol; 1996 Apr; 93(1):81-8. PubMed ID: 8611480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective TCR surface expression associated with impaired TCR beta-chain assembly in a patient with cutaneous T-cell lymphoma.
    Fischer MB; Hauber I; Födinger M; Wolf HM; Thon V; Donath P; Eibl MM; Knobler RM
    J Invest Dermatol; 1995 Apr; 104(4):537-40. PubMed ID: 7706773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma.
    Adachi M; Maeda K; Takekawa M; Hinoda Y; Imai K; Sugiyama S; Yachi A
    Am J Hematol; 1994 Dec; 47(4):278-82. PubMed ID: 7526680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fc gamma RII/III and CD2 expression mark distinct subpopulations of immature CD4-CD8- murine thymocytes: in vivo developmental kinetics and T cell receptor beta chain rearrangement status.
    Rodewald HR; Awad K; Moingeon P; D'Adamio L; Rabinowitz D; Shinkai Y; Alt FW; Reinherz EL
    J Exp Med; 1993 Apr; 177(4):1079-92. PubMed ID: 8096236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic differences between 22 cases of CD56-negative and CD56-positive subcutaneous panniculitis-like lymphoma in Japan.
    Takeshita M; Okamura S; Oshiro Y; Imayama S; Okamoto S; Matsuki Y; Nakashima Y; Okamura T; Shiratsuchi M; Hayashi T; Kikuchi M
    Hum Pathol; 2004 Feb; 35(2):231-9. PubMed ID: 14991542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro expansion of CD3/TCR- human thymocyte populations that selectively lack CD3 delta gene expression: a phenotypic and functional analysis.
    Poggi A; Biassoni R; Pella N; Paolieri F; Bellomo R; Bertolini A; Moretta L; Mingari MC
    J Exp Med; 1990 Nov; 172(5):1409-18. PubMed ID: 2146363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous peripheral T-cell lymphoma of cytotoxic phenotype mimicking extranodal NK/T-cell lymphoma.
    Pan ST; Chang WS; Murphy M; Martinez A; Chuang SS
    Am J Dermatopathol; 2011 Apr; 33(2):e17-20. PubMed ID: 21252637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression.
    Ortaldo JR; Winkler-Pickett RT; Yagita H; Young HA
    Cell Immunol; 1991 Sep; 136(2):486-95. PubMed ID: 1714795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aggressive pleomorphic CD2+, CD3-, CD56+ lymphoma with t(5;9)(q31;q34) abnormality.
    Wong KF; Chan JK; Ma SK; Lai KY
    Cancer Genet Cytogenet; 1995 Jul; 82(1):73-5. PubMed ID: 7543014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating CD4+ T lymphocytes with intracellular but no surface CD3 antigen in five of seven patients consecutively diagnosed with angioimmunoblastic T-cell lymphoma.
    Serke S; van Lessen A; Hummel M; Szczepek A; Huhn D; Stein H
    Cytometry; 2000 Jun; 42(3):180-7. PubMed ID: 10861691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
    Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
    Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatosplenic gamma delta T-cell lymphoma. A distinctive aggressive lymphoma type.
    Wong KF; Chan JK; Matutes E; McCarthy K; Ng CS; Chan CH; Ma SK
    Am J Surg Pathol; 1995 Jun; 19(6):718-26. PubMed ID: 7755158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CD56- and CD4-positive non-Hodgkin's lymphoma of probable T-cell origin].
    Honda S; Ito Y; Otawa M; Katagiri T; Kuriyama Y; Serizawa H; Ebihara Y; Mukai K; Ohyashiki K
    Rinsho Ketsueki; 2001 May; 42(5):420-5. PubMed ID: 11452463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-transplantation lymphoproliferative disease of natural killer cell lineage: a clinicopathological and molecular analysis.
    Kwong YL; Lam CC; Chan TM
    Br J Haematol; 2000 Jul; 110(1):197-202. PubMed ID: 10930998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type.
    Tao Q; Ho FC; Loke SL; Srivastava G
    Int J Cancer; 1995 Jan; 60(3):315-20. PubMed ID: 7829236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.